910 Shares in Danaher Co. (DHR) Purchased by Paragon Capital Management LLC
Paragon Capital Management LLC purchased a new position in shares of Danaher Co. (NYSE:DHR) during the first quarter, HoldingsChannel reports. The firm purchased 910 shares of the conglomerate’s stock, valued at approximately $120,000.
A number of other hedge funds have also recently bought and sold shares of DHR. Norges Bank acquired a new position in Danaher during the 4th quarter worth approximately $747,082,000. Oregon Public Employees Retirement Fund grew its holdings in Danaher by 10,085.3% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,863,048 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 6,795,666 shares during the period. Findlay Park Partners LLP grew its holdings in Danaher by 25.0% during the fourth quarter. Findlay Park Partners LLP now owns 4,595,000 shares of the conglomerate’s stock valued at $473,836,000 after purchasing an additional 920,000 shares during the period. 1832 Asset Management L.P. grew its holdings in Danaher by 74.3% during the fourth quarter. 1832 Asset Management L.P. now owns 2,129,142 shares of the conglomerate’s stock valued at $219,310,000 after purchasing an additional 907,593 shares during the period. Finally, AQR Capital Management LLC grew its holdings in Danaher by 48.2% during the third quarter. AQR Capital Management LLC now owns 2,682,662 shares of the conglomerate’s stock valued at $291,498,000 after purchasing an additional 872,626 shares during the period. 77.58% of the stock is currently owned by institutional investors and hedge funds.
In other Danaher news, SVP Angela S. Lalor sold 4,534 shares of the firm’s stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $127.25, for a total transaction of $576,951.50. Following the sale, the senior vice president now owns 21,209 shares in the company, valued at $2,698,845.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Walter G. Lohr sold 10,578 shares of the firm’s stock in a transaction dated Wednesday, February 27th. The shares were sold at an average price of $126.85, for a total value of $1,341,819.30. Following the sale, the director now owns 20,691 shares in the company, valued at approximately $2,624,653.35. The disclosure for this sale can be found here. Insiders sold 183,150 shares of company stock worth $23,279,637 in the last quarter. 11.90% of the stock is currently owned by company insiders.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. Danaher had a return on equity of 11.64% and a net margin of 13.33%. The company had revenue of $5.40 billion for the quarter, compared to the consensus estimate of $5.33 billion. During the same quarter last year, the business posted $1.19 earnings per share. The firm’s revenue was up 6.2% compared to the same quarter last year. On average, sell-side analysts forecast that Danaher Co. will post 4.79 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date is Thursday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.16. Danaher’s dividend payout ratio (DPR) is 15.04%.
Several equities analysts have weighed in on DHR shares. Zacks Investment Research raised Danaher from a “hold” rating to a “buy” rating and set a $147.00 price objective for the company in a report on Tuesday, April 9th. Needham & Company LLC reaffirmed a “buy” rating and issued a $138.00 price target (up from $114.00) on shares of Danaher in a report on Thursday, February 28th. Jefferies Financial Group raised their price target on Danaher to $140.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Deutsche Bank raised their price target on Danaher to $130.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Finally, UBS Group raised their price target on Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $125.46.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: Why is Cost of Capital Important?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.